Training Program in TB and HIV Prevention and Treatment

该方案的持续目标是培训临床医生、护士、科学家和实验室技术人员。 以及来自印度、喀麦隆和中国的社会工作者在预防、诊断和治疗艾滋病毒和 结核病感染。这一多学科项目包括公立和私立大学的参与， 医院和非政府组织提供旨在改善健康和 他们所服务的人群的福祉。纽约大学AITRP建议与之合作的机构 包括3在印度(医学研究和教育研究生院[昌迪加尔]，全部 印度医学科学研究所[新德里]和爱德华国王纪念医院[孟买])，2英寸 喀麦隆(阿尔法皇家诊所[巴门达]和圣德卫生实验室[雅温得])，中国有3人 (上海市疾控中心、上海市公共卫生中心、上海复旦医学院 大学[上海])。在拟议的供资周期内，将根据需要对候选人进行培训 每个具体国家和所涉机构的情况。因此，尽管这三个国家都面临着艾滋病毒不断上升的问题 和结核病流行，我们在印度的合作机构和中国拥有大量的科学人才和 基础设施，进行旨在改善预防的应用型、基础性科学和/或临床研究， 艾滋病毒和结核病的诊断和治疗。相比之下，喀麦隆的大多数机构缺乏训练有素的 进行这项工作的人力和基础设施。因此，我们合作伙伴提议的培训 印度和中国的机构旨在促进两国之间的合作研究和临床研究 参与机构和纽约大学；我们的目标是提供启动和继续所需的培训 通过为项目的规划和执行提供智力支持以及为获得 为进一步研究提供资金。对于喀麦隆，我们的培训将侧重于支持当地的艾滋病控制项目； 我们将专注于教授技术技能和在可用基础设施内进行设计的开发 实施艾滋病和结核病预防、诊断和治疗的相关计划。而当 计划的细节因地点和国家而异，每个地点的总体目标是相同的：1)到 建立关键的生物医学、实验室和临床科学专业知识；2)促进新的研究工作， 这将补充纽约大学正在进行的旨在预防、诊断和治疗艾滋病毒的研究 和艾滋病毒相关疾病，特别是结核病；3)建立长期合作关系 纽约大学的科学家以及我们在印度、喀麦隆和中国的合作机构；以及4)整合培训 这三个国家正在进行的预防、诊断和治疗研究工作。这样做的目的是 该计划将通过在纽约大学的长期和短期培训以及通过培训讲习班和 在我们的伙伴机构举办研讨会。

The continuing goal for this program is the training of clinicians, nurses, scientists, laboratory technicians and social workers from India, Cameroon, and China in the prevention, diagnosis, and treatment of HIV and TB infections. This multidisciplinary program includes the participation of public and private universities, hospitals, and non-governmental organizations that provide services designed to improve the health and well-being of the populations they serve. The institutions with which the NYU AITRP proposes to collaborate nclude 3 in India (the Post Graduate Institute for Medical Research and Education [Chandigarh], the All India Institute of Medical Sciences [NewDelhi] and King Edward Memorial Hospital [Mumbai]), 2 in Cameroon (Alpha Royal Clinic [Bamenda] and the Laboratoire de Sante Hygiene [Yaounde]), and 3 in China (the Shanghai CDC, the Shanghai Public Health Center and the Shanghai Medical College of Fudan University [Shanghai]). During the proposed funding cycle, training of candidates will be tailored to the needs of each specific country and those of the institutions involved. Thus, while all 3 countries face escalating HIV and TB epidemics, our partner institutions in India and China possess much of the scientific talent and infrastructure to conduct applied, basic scientific, and/or clinical research designed to improve prevention, diagnosis and treatment of HIV and TB. In contrast, most institutions in Cameroon lack the trained manpower and infrastructure to conduct such work. Consequently, the proposed training at our partner institutions in India and China aims to foster collaborative research and clinical studies between the participating institutions and with NYU; our goal is to supply the training needed to initiate and continue relevant research by providing intellectual support for planning and execution of projects and for obtaining funding for further studies. For Cameroon, our training will focus on supporting local AIDS control programs; we will focus on teaching technical skills and on the development within the available infrastructure to design and implement relevant programs in the prevention, diagnosis, and treatment of HIV and TB. While the details of the program differ between the sites and countries, the overall goals are the same for each: 1) to establish critical biomedical, laboratory and clinical science expertise; 2) to facilitate new research efforts, which will complement the ongoing research at NYU, aimed at prevention, diagnosis and treatment of HIV and HIV-related diseases, especially TB; 3) to establish long-term collaborative relationships between scientists at NYU and our partner institutions in India, Cameroon, and China; and 4) to integrate the training into ongoing prevention, diagnosis and treatment research efforts in the 3 countries. The goals of this program will be achieved through long- and short-term training at NYU and through training workshops and seminars at our partner institutions.